Home > Publications Database > A multi-omics dataset for the analysis of frontotemporal dementia genetic subtypes. > print |
001 | 266115 | ||
005 | 20240112171155.0 | ||
024 | 7 | _ | |a 10.1038/s41597-023-02598-x |2 doi |
024 | 7 | _ | |a pmid:38040703 |2 pmid |
024 | 7 | _ | |a pmc:PMC10692098 |2 pmc |
024 | 7 | _ | |a 2052-4436 |2 ISSN |
024 | 7 | _ | |a 2052-4463 |2 ISSN |
024 | 7 | _ | |a altmetric:157320434 |2 altmetric |
037 | _ | _ | |a DZNE-2023-01109 |
041 | _ | _ | |a English |
082 | _ | _ | |a 500 |
100 | 1 | _ | |a Menden, Kevin |0 P:(DE-2719)2812499 |b 0 |e First author |u dzne |
245 | _ | _ | |a A multi-omics dataset for the analysis of frontotemporal dementia genetic subtypes. |
260 | _ | _ | |a London |c 2023 |b Nature Publ. Group |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1701783550_15105 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Understanding the molecular mechanisms underlying frontotemporal dementia (FTD) is essential for the development of successful therapies. Systematic studies on human post-mortem brain tissue of patients with genetic subtypes of FTD are currently lacking. The Risk and Modyfing Factors of Frontotemporal Dementia (RiMod-FTD) consortium therefore has generated a multi-omics dataset for genetic subtypes of FTD to identify common and distinct molecular mechanisms disturbed in disease. Here, we present multi-omics datasets generated from the frontal lobe of post-mortem human brain tissue from patients with mutations in MAPT, GRN and C9orf72 and healthy controls. This data resource consists of four datasets generated with different technologies to capture the transcriptome by RNA-seq, small RNA-seq, CAGE-seq, and methylation profiling. We show concrete examples on how to use the resulting data and confirm current knowledge about FTD and identify new processes for further investigation. This extensive multi-omics dataset holds great value to reveal new research avenues for this devastating disease. |
536 | _ | _ | |a 354 - Disease Prevention and Healthy Aging (POF4-354) |0 G:(DE-HGF)POF4-354 |c POF4-354 |f POF IV |x 0 |
536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 1 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
650 | _ | 2 | |a Humans |2 MeSH |
650 | _ | 2 | |a Frontal Lobe |2 MeSH |
650 | _ | 2 | |a Frontotemporal Dementia: genetics |2 MeSH |
650 | _ | 2 | |a Multiomics |2 MeSH |
650 | _ | 2 | |a Mutation |2 MeSH |
700 | 1 | _ | |a Francescatto, Margherita |0 P:(DE-2719)2810784 |b 1 |
700 | 1 | _ | |a Nyima, Tenzin |0 P:(DE-2719)2811886 |b 2 |
700 | 1 | _ | |a Blauwendraat, Cornelis |0 P:(DE-2719)2810837 |b 3 |
700 | 1 | _ | |a Dhingra, Ashutosh |0 P:(DE-2719)2811729 |b 4 |u dzne |
700 | 1 | _ | |a Castillo Lizardo, Melissa Gissel |0 P:(DE-2719)2810917 |b 5 |u dzne |
700 | 1 | _ | |a Fernandes, Noémia |0 P:(DE-2719)2811866 |b 6 |u dzne |
700 | 1 | _ | |a Kaurani, Lalit |0 P:(DE-2719)2812832 |b 7 |u dzne |
700 | 1 | _ | |a Kronenberg-Versteeg, Deborah |0 P:(DE-2719)9001451 |b 8 |u dzne |
700 | 1 | _ | |a Atasu, Burcu |0 P:(DE-2719)2812917 |b 9 |
700 | 1 | _ | |a Sadikoglou, Eldem |0 P:(DE-2719)9001460 |b 10 |
700 | 1 | _ | |a Borroni, Barbara |0 P:(DE-HGF)0 |b 11 |
700 | 1 | _ | |a Rodriguez-Nieto, Salvador |0 P:(DE-2719)2812129 |b 12 |u dzne |
700 | 1 | _ | |a Simon Sanchez, Javier |0 P:(DE-2719)2811198 |b 13 |
700 | 1 | _ | |a Fischer, Andre |0 P:(DE-2719)2000047 |b 14 |u dzne |
700 | 1 | _ | |a Craig, David Wesley |0 P:(DE-HGF)0 |b 15 |
700 | 1 | _ | |a Neumann, Manuela |0 P:(DE-2719)2810592 |b 16 |u dzne |
700 | 1 | _ | |a Bonn, Stefan |0 P:(DE-2719)2810547 |b 17 |u dzne |
700 | 1 | _ | |a Rizzu, Patrizia |0 P:(DE-2719)2810718 |b 18 |u dzne |
700 | 1 | _ | |a Heutink, Peter |0 P:(DE-2719)2810728 |b 19 |
773 | _ | _ | |a 10.1038/s41597-023-02598-x |g Vol. 10, no. 1, p. 849 |0 PERI:(DE-600)2775191-0 |n 1 |p 849 |t Scientific data |v 10 |y 2023 |x 2052-4436 |
856 | 4 | _ | |u https://pub.dzne.de/record/266115/files/DZNE-2023-01109.pdf |y OpenAccess |
856 | 4 | _ | |u https://pub.dzne.de/record/266115/files/DZNE-2023-01109.pdf?subformat=pdfa |x pdfa |y OpenAccess |
909 | C | O | |o oai:pub.dzne.de:266115 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2812499 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2810784 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2811886 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2810837 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)2811729 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 5 |6 P:(DE-2719)2810917 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 6 |6 P:(DE-2719)2811866 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 7 |6 P:(DE-2719)2812832 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 8 |6 P:(DE-2719)9001451 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)2812917 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 10 |6 P:(DE-2719)9001460 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 12 |6 P:(DE-2719)2812129 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 13 |6 P:(DE-2719)2811198 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 14 |6 P:(DE-2719)2000047 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 16 |6 P:(DE-2719)2810592 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 17 |6 P:(DE-2719)2810547 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 18 |6 P:(DE-2719)2810718 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 19 |6 P:(DE-2719)2810728 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-354 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Prevention and Healthy Aging |x 0 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 1 |
914 | 1 | _ | |y 2023 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-10-26 |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b SCI DATA : 2022 |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-05-02T09:09:14Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-05-02T09:09:14Z |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-26 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-26 |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2023-05-02T09:09:14Z |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2023-10-26 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b SCI DATA : 2022 |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-26 |
920 | 1 | _ | |0 I:(DE-2719)1210002 |k AG Heutink |l Genome Biology of Neurodegenerative Diseases |x 0 |
920 | 1 | _ | |0 I:(DE-2719)1210009 |k AG Rizzu |l Applied Genomics for Neurodegenerative Diseases |x 1 |
920 | 1 | _ | |0 I:(DE-2719)1410002 |k AG Fischer |l Epigenetics and Systems Medicine in Neurodegenerative Diseases |x 2 |
920 | 1 | _ | |0 I:(DE-2719)1210001 |k AG Jucker |l Cell Biology of Neurological Diseases |x 3 |
920 | 1 | _ | |0 I:(DE-2719)1210003 |k AG Neumann |l Molecular Neuropathology of Neurodegenerative Diseases |x 4 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-2719)1210002 |
980 | _ | _ | |a I:(DE-2719)1210009 |
980 | _ | _ | |a I:(DE-2719)1410002 |
980 | _ | _ | |a I:(DE-2719)1210001 |
980 | _ | _ | |a I:(DE-2719)1210003 |
980 | _ | _ | |a UNRESTRICTED |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|